Pharmacological Characterization of µ-Opioid Receptor Agonists with Biased G Protein or β-Arrestin Signaling, and Computational Study of Conformational Changes during Receptor Activation
In recent years, G protein vs. β-arrestin biased agonism at opioid receptors has been proposed as an opportunity to produce antinociception with reduced adverse effects. However, at present this approach is highly debated, a reason why more information about biased ligands is required. While the pra...
Main Authors: | Justyna Piekielna-Ciesielska, Roberto Artali, Ammar A. H. Azzam, David G. Lambert, Alicja Kluczyk, Luca Gentilucci, Anna Janecka |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-12-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/26/1/13 |
Similar Items
-
Functional selectivity of EM-2 analogs at the mu-opioid receptor
by: Justyna Piekielna-Ciesielska, et al.
Published: (2023-02-01) -
The Opioid Receptor Influences Circadian Rhythms in Human Keratinocytes through the β-Arrestin Pathway
by: Paul Bigliardi, et al.
Published: (2024-01-01) -
Harnessing the Anti-Nociceptive Potential of NK2 and NK3 Ligands in the Design of New Multifunctional μ/δ-Opioid Agonist–Neurokinin Antagonist Peptidomimetics
by: Charlène Gadais, et al.
Published: (2021-09-01) -
ß-arrestin 2 germline knockout does not attenuate opioid respiratory depression
by: Iris Bachmutsky, et al.
Published: (2021-05-01) -
Exploration of beta-arrestin isoform signaling pathways in delta opioid receptor agonist-induced convulsions
by: Arryn T. Blaine, et al.
Published: (2022-08-01)